An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer

Area of Science:

• Urology
• Radiology
• Oncology

Background:

• Nodal recurrence of prostate cancer poses a significant challenge after initial treatments like radical prostatectomy and salvage therapies.
• Accurate staging and detection of metastatic disease are crucial for guiding subsequent treatment strategies in recurrent prostate cancer.

Observation:

• A 54-year-old man with recurrent prostate cancer underwent advanced imaging, including ultrasmall superparamagnetic iron oxide-enhanced MRI (USPIO-MRI) and Gallium-68 labeled prostate-specific membrane antigen PET-CT (Ga68-PSMA PET-CT).
• Preoperative imaging suggested localized nodal disease, leading to consideration for a second robot-assisted salvage lymph node dissection (S-LND).

Findings:

• Pathological examination post-surgery revealed extensive nodal involvement, indicating widespread metastatic disease that was not fully appreciated on preoperative imaging.
• This discrepancy underscores the limitations of current lymph node imaging modalities in accurately assessing the extent of nodal metastasis in prostate cancer recurrence.

Implications:

• The findings suggest that advanced imaging techniques may underestimate the true burden of nodal metastasis in recurrent prostate cancer.
• This highlights the need for improved imaging strategies or careful interpretation of imaging findings in the context of potential understaging.
• Such limitations can impact surgical planning and the effectiveness of salvage therapies for recurrent prostate cancer.